Synendos is a clinical stage neuroscience company developing potentially breakthrough safe and effective therapies for neuropsychiatric and neurological disorders through the modulation of a new drug target in the endocannabinoid system enabling restoration of the natural functioning of the brain.

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    10-19

Key business

Keep browsing

You may also be interested in